In this episode, we delve into immunotherapy which offers a unique approach compared to targeted therapy. We'll explore how immunotherapy has dramatically shifted the prognosis for lung cancer patients, especially those with advanced disease
Our discussion will break down the science behind the PD-1/PD-L1 pathway, explaining how blocking this interaction can reactivate your immune system to combat cancer and potentially provide long-term benefits. We’ll also address its possible side effects, ensuring you have a balanced perspective on the treatment.
By the end of this episode, our goal is to empower you with the knowledge to confidently discuss PD-L1 immunotherapy with your healthcare team, including assessing its suitability and potential benefits for your specific case.
Source: L’Hopital d’Ottawa
See More HERE